NCT06488573

Brief Summary

Individuals with Bipolar Disorder (BD) have twice the risk of being affected by metabolic comorbidities and a 1.8-fold increased risk of mortality from cardiovascular diseases when compared to the general population. These factors are fundamental in the 14-year reduction in the life expectancy of people with TB reported in recent meta-analyses. This occurs mainly due to the increased inflammation associated with the disease, the adverse effects of pharmacological treatments and unhealthy lifestyle habits that are more common in people diagnosed with BD. Nutrition has been studied as an adjunctive treatment in other psychiatric disorders, but there is a lack of studies about the role of nutrition in TB. Considering that diet can impact metabolic health, this randomized controlled study aims to evaluate the effect of a nutritional intervention on cardiovascular risk in patients with TB. The intervention is based on the dietary pattern recommended in the Dietary Guidelines for the Brazilian Population and will be applied by a registered dietitian. According to the literature, the sample size will be 72 individuals with TB (36 in the control group with usual treatment + 36 in the intervention group added to the usual treatment). The intervention will be carried out in 7 individual sessions and 8 group sessions with specific themes. The primary aim of this protocol will be an intervention to contribute to cardiovascular health - verified by serum markers, anthropometric measurements and the Framingham Cardiovascular Risk Score (algorithm used to estimate an individual's 10-year cardiovascular risk). The secondary stages will be the adherence of the intervention and the impact on the quality of life of the participants. The possible positive results of this nutritional intervention can open new clinical perspectives. Meaning that might show that better food choices can protect the cardiovascular health of individuals with TB, leading to a reduction in morbidity and mortality associated with the disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
88

participants targeted

Target at P50-P75 for not_applicable

Timeline
17mo left

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress12%
Apr 2026Dec 2027

First Submitted

Initial submission to the registry

June 17, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

July 5, 2024

Completed
1.7 years until next milestone

Study Start

First participant enrolled

April 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

March 2, 2026

Status Verified

February 1, 2026

Enrollment Period

7 months

First QC Date

June 17, 2024

Last Update Submit

February 26, 2026

Conditions

Keywords

nutrition interventionnutritional psychiatrybipolar disorderdietary interventionbrazilian dietary guideline

Outcome Measures

Primary Outcomes (11)

  • C reactive protein

    C reactive protein

    Baseline, week 12, week 24 and follow up at week 52

  • Total cholesterol and fractions

    Total cholesterol and fractions

    Baseline, week 12, week 24 and follow up at week 52

  • Glycemia

    Glycemia

    Baseline, week 12, week 24 and follow up at week 52

  • Glycated hemoglobin A1C

    Glycated hemoglobin A1C

    Baseline, week 12, week 24 and follow up at week 52

  • Triglycerides

    Triglycerides

    Baseline, week 12, week 24 and follow up at week 52

  • HOMA IR

    HOME IR

    Baseline, week 12, week 24 and follow up at week 52

  • Apoliporpotein B

    Apoliporpotein B

    Baseline, week 12, week 24 and follow up at week 52

  • Cardiovascular risk

    Framingham Global Risk Score (-3 to 21; higher scores mean worse outcome)

    Baseline, week 12, week 24 and follow up at week 52

  • Body weight

    Body weight

    Baseline, week 12, week 24 and follow up at week 52

  • Body fat percentage

    Body fat percentage

    Baseline, week 12, week 24 and follow up at week 52

  • waist circumference

    waist circumference

    Baseline, week 12, week 24 and follow up at week 52

Secondary Outcomes (4)

  • Dietary assessment - dietary intake

    Baseline, week 12, week 24 and follow up at week 52

  • Dietary assessment - dietary quality

    Baseline, week 12, week 24 and follow up at week 52

  • Dietary assessment - dietary adehrence

    Baseline, week 12, week 24 and follow up at week 52

  • Quality of life WHOQOL

    Baseline, week 12, week 24 and follow up at week 52

Study Arms (2)

Treatment as usual

NO INTERVENTION

Treatment as usual

Nutritional intervention

EXPERIMENTAL

Nutritional intervention based on the Brazilian Dietary Guidelines

Behavioral: Nutritional intervention

Interventions

7 individual sessions (online) + 6 small group sessions (1-in person + 5 online)

Nutritional intervention

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Clinical diagnosis of Bipolar disorder types I and II diagnosis
  • Adults of both genders, from 18 to 60 years old
  • In typical pharmacotherapy for BD, for at least one month
  • Agreement to participate in the study with signature of the consent form

You may not qualify if:

  • Patients with "very good or excellent" diet quality assessed by the diet quality scale (ESQUADA): \>275 out of a score of 375
  • Patients in a state of hypomania or mania: score \>8 (Young Mania Rating Scale - YMRS)
  • Patients with severe depression \>21 Montgomery-Åsberg Depression Rating Scale
  • Patients at low cardiovascular risk (\<7 points for men or \<9 points for women on the Framingham Global Risk Score)
  • Low weight or eutrophic body mass index: \<25kg/m² as in similar studies
  • Pregnant or breastfeeding women
  • Patients diagnosed with anorexia and bulimia nervosa
  • Patientes diagnosed with Irritable Bowl Syndrome or other diagnosed conditions that affect the gastrointestinal function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fernanda Gabriel

São Paulo, São Paulo, 04514102, Brazil

RECRUITING

MeSH Terms

Conditions

Bipolar Disorder

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Control group vs intervention group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associated professor

Study Record Dates

First Submitted

June 17, 2024

First Posted

July 5, 2024

Study Start

April 1, 2026

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 1, 2027

Last Updated

March 2, 2026

Record last verified: 2026-02

Locations